|
TMO
|
Thermo Fisher Scientific Inc
|
6.26%
|
US
|
NYSE
|
|
DHR
|
Danaher Corporation
|
5.86%
|
US
|
NYSE
|
|
RGEN
|
Repligen Corporation
|
5.16%
|
US
|
NASDAQ
|
|
MEDP
|
Medpace Holdings, Inc.
|
4.55%
|
US
|
NASDAQ
|
|
MRNA
|
Moderna, Inc.
|
4.25%
|
US
|
NASDAQ
|
|
SRT3
|
Sartorius Aktiengesellschaft
|
3.88%
|
DE
|
XETRA
|
|
207940
|
Samsung Biologics Co Ltd
|
3.47%
|
KR
|
KO
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
3.47%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
3.33%
|
US
|
NASDAQ
|
|
CTVA
|
Corteva, Inc.
|
3.13%
|
US
|
NYSE
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
2.87%
|
US
|
NASDAQ
|
|
BRKR
|
Bruker Corporation
|
2.69%
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
2.62%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
2.50%
|
US
|
NASDAQ
|
|
QGEN
|
Qiagen N.V.
|
2.41%
|
US
|
NYSE
|
|
A
|
Agilent Technologies, Inc.
|
2.41%
|
US
|
NYSE
|
|
CRL
|
Charles River Laboratories International, Inc.
|
2.34%
|
US
|
NYSE
|
|
BNTX
|
BioNTech SE
|
2.30%
|
US
|
NASDAQ
|
|
LONN
|
Lonza Group AG
|
2.05%
|
CH
|
SW
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
2.03%
|
US
|
NASDAQ
|